Hindbrain Ghrelin Receptor Signaling Is Sufficient to Maintain Fasting Glucose

• Michael M. Scott,

  Affiliations Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯
• Mario Perello,

  Current address: Laboratory of Neurophysiology, Multidisciplinary Institute of Cell Biology, La Plata, Buenos Aires, Argentina

  Affiliation Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Jen-Chieh Chuang,

  Affiliation Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Ichiro Sakata,

  Affiliation Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Laurent Gautron,

  Affiliation Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Charlotte E. Lee,

  Affiliation Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Danielle Lauzon,

  Affiliation Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Joel K. Elmquist ,

  Contributed equally to this work with: Joel K. Elmquist, Jeffrey M. Zigman

  * E-mail: joel.elmquist@utsouthwestern.edu (JKE); jeffrey.zigman@utsouthwestern.edu (JMZ)

  Affiliations Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Division of Endocrinology & Metabolism, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Pharmacology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯
• Jeffrey M. Zigman

  Contributed equally to this work with: Joel K. Elmquist, Jeffrey M. Zigman

  * E-mail: joel.elmquist@utsouthwestern.edu (JKE); jeffrey.zigman@utsouthwestern.edu (JMZ)

  Affiliations Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Division of Endocrinology & Metabolism, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America

  ⨯